Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Stryker (SYK) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with speci ...

Here are three stocks with buy rank and strong value characteristics for investors to consider today, March 16:OptimizeRx Corporation (OPRX) : This digital healthcare technology company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing by 12.6% over the last 60 days.OptimizeRx has a price-to-earnings ratio (P/E) of 6.53 compared with 17.60 for the industry. The company possesses a Value Scoreof A.Envista Holdings Corporation (NVST) : This dental ...

Core Viewpoint - Envista (NVST) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Group 1: Zacks Rating System - The Zacks rating system is based solely on a company's changing earnings picture, which is a critical factor in stock price movements [2][4]. - The system tracks the Zacks Consensus Estimate, which aggregates EPS estimates from sell-side analysts, reflecting the market's expectations for the company's earnings [1][4]. Group 2: Earnings Estimate Revisions - The upgrade for Envista signifies an improvement in its underlying business, as rising earnings estimates are correlated with increased stock prices due to institutional investors' actions [5][6]. - Over the past three months, the Zacks Consensus Estimate for Envista has increased by 12.4%, with expected earnings of $1.41 per share for the fiscal year ending December 2026, indicating no year-over-year change [8]. Group 3: Historical Performance - The Zacks Rank system has a strong track record, with Zacks Rank 1 stocks generating an average annual return of +25% since 1988, showcasing the effectiveness of earnings estimate revisions in predicting stock performance [7][9]. - Stocks in the top 20% of the Zacks-covered universe are positioned for potential market-beating returns, with Envista's upgrade placing it in the top 5% based on estimate revisions [10].

Core Viewpoint - Investors are evaluating the value opportunities between Envista (NVST) and EssilorLuxottica Unsponsored ADR (ESLOY), with NVST currently presenting a more favorable investment option based on various financial metrics [1]. Group 1: Zacks Rank and Earnings Outlook - Envista has a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision trend, while EssilorLuxottica has a Zacks Rank of 4 (Sell), suggesting a less favorable outlook [3]. - The improving earnings outlook for NVST positions it as a strong candidate for value investors [7]. Group 2: Valuation Metrics - NVST has a forward P/E ratio of 19.86, significantly lower than ESLOY's forward P/E of 28.16, indicating that NVST may be undervalued relative to its earnings potential [5]. - The PEG ratio for NVST is 1.91, compared to ESLOY's PEG ratio of 2.99, further suggesting that NVST offers better value when considering expected earnings growth [5]. - NVST's P/B ratio stands at 1.48, while ESLOY's P/B ratio is 2.67, reinforcing the notion that NVST is more attractively priced relative to its book value [6]. - Based on these valuation metrics, NVST has earned a Value grade of B, whereas ESLOY has a Value grade of D, indicating a stronger value proposition for NVST [6].

Core Viewpoint - The comparison between Envista (NVST) and EssilorLuxottica Unsponsored ADR (ESLOY) indicates that NVST presents a better value investment opportunity at this time due to its stronger Zacks Rank and favorable valuation metrics [1][3][7] Valuation Metrics - NVST has a forward P/E ratio of 20.01, while ESLOY has a significantly higher forward P/E of 31.31 [5] - The PEG ratio for NVST is 1.92, indicating a more favorable valuation in relation to its expected earnings growth compared to ESLOY's PEG ratio of 3.23 [5] - NVST's P/B ratio stands at 1.49, which is lower than ESLOY's P/B ratio of 3.05, suggesting that NVST is undervalued relative to its book value [6] Earnings Outlook - NVST is currently experiencing an improving earnings outlook, which is a positive indicator in the Zacks Rank model, further supporting its position as a superior value option [3][7]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ FORM 10-K ENVISTA HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 83-2206728 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) ...

Key Takeaways NVST reported Q4 adjusted EPS of 38 cents, up 58%, with revenues rising 15% and beating estimates.NVST's Specialty Products & Technologies and Equipment & Consumables posted double-digit sales growth.NVST saw gross margin fall 235 bps on higher costs, but operating margin expanded to 9.8%.Envista Holdings Corporation (NVST) reported adjusted earnings per share (EPS) of 38 cents in the fourth quarter of 2025, up 58.3% year over year. The bottom line surpassed the Zacks Consensus Estimate by 18. ...

Core Insights - Zacks Premium offers various tools to enhance stock market investment confidence and knowledge, including daily updates, research reports, and stock screens [1][2] Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum methodologies, helping investors identify stocks likely to outperform the market in the short term [3] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [4] Value Score - The Value Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Sales [4] Growth Score - The Growth Score assesses a company's financial health and future outlook, analyzing projected earnings, sales, and cash flow to find sustainable growth stocks [5] Momentum Score - The Momentum Score evaluates stocks based on price trends and earnings outlook changes, helping investors capitalize on upward or downward price movements [6] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive rating that highlights stocks with attractive value, growth potential, and positive momentum [7] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify stock selection, with 1 (Strong Buy) stocks achieving an average annual return of +23.83% since 1988, significantly outperforming the S&P 500 [8][9] - Investors are encouraged to focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal returns [10] Stock Highlight: Envista Holdings Corporation (NVST) - Envista, a subsidiary of Danaher Corporation, specializes in the dental sector and has integrated over 25 dental businesses [12] - NVST holds a 1 (Strong Buy) Zacks Rank and a VGM Score of A, indicating strong investment potential [12] - The company is projected to achieve year-over-year earnings growth of 17.7% for the current fiscal year, with recent earnings estimates revised upward [13] - With a solid Zacks Rank and favorable Growth and VGM Style Scores, NVST is recommended for investors [14]

Core Viewpoint - Envista (NVST) is positioned as a strong investment opportunity due to its improving earnings outlook and positive analyst sentiment [1][2]. Earnings Estimate Revisions - Analysts are increasingly optimistic about Envista's earnings prospects, leading to a rising trend in estimate revisions, which typically correlates with stock price movements [2]. - The current-quarter earnings estimate is projected at $0.30 per share, reflecting a year-over-year increase of +25.0%, with a recent 11.64% rise in consensus estimates over the last 30 days [5][6]. - For the full year, the earnings estimate is expected to be $1.36 per share, indicating a year-over-year change of +14.3%, with a 7.96% increase in consensus estimates due to five upward revisions [6][7]. Zacks Rank and Performance - Envista has achieved a Zacks Rank 1 (Strong Buy), indicating strong agreement among analysts on upward earnings revisions, which historically leads to significant outperformance [3][8]. - Stocks with a Zacks Rank 1 and 2 have shown to significantly outperform the S&P 500, suggesting a favorable investment environment for Envista [8]. Stock Performance - Envista's stock has increased by 23.2% over the past four weeks, driven by strong estimate revisions, indicating potential for further upside [9].

Core Viewpoint - Envista (NVST) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook for its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, which in turn affects stock prices [4]. Business Improvement Indicators - Rising earnings estimates and the Zacks Rank upgrade suggest an improvement in Envista's underlying business, which could lead to increased stock prices as investors respond positively to this trend [5][10]. - Over the past three months, the Zacks Consensus Estimate for Envista has increased by 8.3%, indicating a positive revision in earnings expectations [8]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions, positioning Envista favorably for potential market-beating returns [9][10].